Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03834688 |
Title | Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) |
Acronym | PrE0405 |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | PrECOG, LLC. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Carle Cancer Center | Urbana | Illinois | 61801 | United States | Details | |
Indiana University Simon Cancer Center | Indianapolis | Indiana | 46202 | United States | Details | |
St. Joseph Mercy Hospital Cancer Care Center | Ann Arbor | Michigan | 48106 | United States | Details | |
Mayo Clinic | Rochester | Minnesota | 55905 | United States | Details | |
Washington University School of Medicine Siteman Cancer Center | Saint Louis | Missouri | 63110 | United States | Details | |
Penn State Cancer Institute | Hershey | Pennsylvania | 17033 | United States | Details | |
University of Virginia Health System | Charlottesville | Virginia | 22903 | United States | Details |